Stay updated on BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page.

Latest updates to the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page
- Check2 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer revision marker changes from v3.7.0 to v3.7.1; the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content. This blocks access to the study details and related information on that page.SummaryDifference19%

- Check52 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a small update to the page's version; this does not modify the study details or outcomes.SummaryDifference0.1%

- Check73 days agoChange DetectedFooter metadata updated to Revision: v3.6.5, signaling a new revision of the page. The Investigator Inquiry Form and the previous Revision: v3.6.4 entry were removed, indicating a cleanup of footer items.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.6.4 was added and Revision: v3.6.3 was removed, indicating a small behind-the-scenes update to the page’s versioning or documentation that does not change the study details.SummaryDifference0.1%

Stay in the know with updates to BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page.